Sakar Healthcare Limited (SAKAR) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.101x

Based on the latest financial reports, Sakar Healthcare Limited (SAKAR) has a cash flow conversion efficiency ratio of 0.101x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs305.87 Million ≈ $3.31 Million USD) by net assets (Rs3.03 Billion ≈ $32.80 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See SAKAR equity financing ratio to measure how much of total assets are equity-financed.

Sakar Healthcare Limited - Cash Flow Conversion Efficiency Trend (2010–2026)

This chart illustrates how Sakar Healthcare Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check SAKAR cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Sakar Healthcare Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sakar Healthcare Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Giantplus Technology Co Ltd TW:8105	0.004x
Paramount Communications Limited NSE:PARACABLES	-0.072x
Cathay Chemical Works Inc TW:1713	0.062x
Pulmuone Holdi KO:017810	0.016x
Qinghaihuading Industrial Co Ltd SHG:600243	-0.009x
Kaset Thai International Sugar Corporation Public Company Limited BK:KTIS	0.212x
Blue Acquisition Corp. Class A Ordinary Shares NASDAQ:BACC	-0.001x
AME Elite Consortium Bhd KLSE:5293	-0.137x

Annual Cash Flow Conversion Efficiency for Sakar Healthcare Limited (2010–2026)

The table below shows the annual cash flow conversion efficiency of Sakar Healthcare Limited from 2010 to 2026. For the full company profile with market capitalisation and key ratios, see Sakar Healthcare Limited (SAKAR) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	Rs3.24 Billion ≈ $35.09 Million	Rs393.71 Million ≈ $4.26 Million	0.121x	+1.79%
2025-03-31	Rs2.85 Billion ≈ $30.87 Million	Rs340.32 Million ≈ $3.68 Million	0.119x	+27.82%
2024-03-31	Rs2.62 Billion ≈ $28.37 Million	Rs244.67 Million ≈ $2.65 Million	0.093x	-54.22%
2023-03-31	Rs1.73 Billion ≈ $18.75 Million	Rs353.14 Million ≈ $3.82 Million	0.204x	-27.26%
2022-03-31	Rs1.27 Billion ≈ $13.78 Million	Rs356.99 Million ≈ $3.86 Million	0.280x	+89.16%
2021-03-31	Rs984.52 Million ≈ $10.65 Million	Rs145.77 Million ≈ $1.58 Million	0.148x	+18.92%
2020-03-31	Rs813.20 Million ≈ $8.79 Million	Rs101.25 Million ≈ $1.09 Million	0.125x	-53.27%
2019-03-31	Rs717.04 Million ≈ $7.75 Million	Rs191.03 Million ≈ $2.07 Million	0.266x	+160.56%
2018-03-31	Rs514.93 Million ≈ $5.57 Million	Rs52.65 Million ≈ $569.38K	0.102x	+18606825.53%
2017-03-31	Rs355.03 Million ≈ $3.84 Million	Rs195.09 ≈ $2.11	0.000x	-88.53%
2016-03-31	Rs191.82 Million ≈ $2.07 Million	Rs918.64 ≈ $9.93	0.000x	-100.00%
2015-03-31	Rs148.28 Million ≈ $1.60 Million	Rs41.76 Million ≈ $451.59K	0.282x	-54.40%
2014-03-31	Rs138.71 Million ≈ $1.50 Million	Rs85.67 Million ≈ $926.46K	0.618x	+13.02%
2013-03-31	Rs121.19 Million ≈ $1.31 Million	Rs66.23 Million ≈ $716.22K	0.546x	+160.66%
2012-03-31	Rs137.59 Million ≈ $1.49 Million	Rs28.84 Million ≈ $311.95K	0.210x	+1.82%
2011-03-31	Rs132.75 Million ≈ $1.44 Million	Rs27.33 Million ≈ $295.59K	0.206x	+2334.89%
2010-03-31	Rs123.53 Million ≈ $1.34 Million	Rs-1.14 Million ≈ $-12.31K	-0.009x	--

About Sakar Healthcare Limited

NSE:SAKAR India Drug Manufacturers - Specialty & Generic

Market Cap

$218.98 Million

Rs20.25 Billion INR

Market Cap Rank

#16177 Global

#845 in India

Share Price

Rs922.50

Change (1 day)

+4.21%

52-Week Range

Rs317.10 - Rs922.50

All Time High

Rs922.50